IUPAC name
ethyl 2-(4-chlorophenoxy)-2-methylpropanoate
SMILES
CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
Compound class
Anticholesteremic Agents; Hypolipidemic Agents; Lipid Modifying Agents, Plain; Lipid Modifying Agents; Cardiovascular System; Fibrates; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2A6 Inhibitors; CYP2A6 Inhibitors (strong); CYP2A6 Inhibitors (moderate); CYP2A6 Inducers; CYP2A6 Inducers (strong); CYP2B6 Inhibitors (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors;
Therapeutic area
For Primary Dysbetalipoproteinemia (Type III hyperlipidemia) that does not respond adequately to diet. This helps control high cholesterol and high triglyceride levels.
Common name
Clofibrate
IUPAC name
ethyl 2-(4-chlorophenoxy)-2-methylpropanoate
SMILES
CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
INCHI
InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3
FORMULA
C12H15ClO3
Common name
Clofibrate
IUPAC name
ethyl 2-(4-chlorophenoxy)-2-methylpropanoate
Molecular weight
242.699
clogP
3.012
clogS
-3.459
HBond Acceptor
3
HBond Donor
0
Total Polar Surface Area
35.53
Number of Rings
1
Rotatable Bond
5
| Drug ID | Common name | Structure CAS | SMILE | Frequency |
|---|---|---|---|---|
| FDBF00007 | propane |
|
C(C)C | 0.2412 |
| FDBF00016 | chlorobenzene |
|
c1ccc(cc1)Cl | 0.0718 |
| FDBF00042 | propan-2-ol |
|
CC(O)C | 0.0278 |
| FDBF00100 | ethyl formate |
|
O(C=O)CC | 0.0244 |
| FDBF01437 | 4-chlorophenol |
|
Oc1ccc(cc1)Cl | 0.0072 |
| FDBF01438 | ethyl 2-methylpropanoate |
|
C(C)(C)C(=O)OCC | 0.0007 |
| FDBF01439 | 1-chloro-4-isopropoxy-benzene |
|
O(c1ccc(cc1)Cl)C(C)C | 0.0010 |
| FDBF01440 | ethyl 2-hydroxy-2-methyl-propanoate |
|
OC(C)(C)C(=O)OCC | 0.0003 |
